EUS: endoscopic ultrasound; GIST: gastrointestinal stromal tumor.
* EUS surveillance may be offered after a risk-benefit discussion with the patient. Data are limited for the optimal interval between surveillance studies. One approach is to have a short-term initial assessment (eg, within three to six months). If the tumor remains stable, then the follow-up interval can be lengthened. The tumor should be resected if it cannot be assessed endoscopically, becomes symptomatic (eg, dysphagia), increases in size, or shows structural changes or high-risk endoscopic features on EUS. Refer to UpToDate content on local treatment for GIST.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟